Document Detail

Serum vimentin methylation as a potential marker for colorectal cancer.
MedLine Citation:
PMID:  25075038     Owner:  NLM     Status:  In-Data-Review    
AIMS: The present study aimed to examine the feasibility of detecting vimentin (VIM) methylation in the serum of patients with colorectal cancer (CRC) and to determine the effectiveness of a relatively simple, inexpensive, and non-invasive test performed in combination with the conventional carcinoembryonic antigen analysis.
MATERIALS AND METHODS: VIM methylation in the serum DNA of 242 patients with CRC was measured by a quantitative methylation-specific polymerase chain reaction.
RESULTS: A significantly higher positive rate was obtained for VIM methylation than for carcinoembryonic antigen or carbohydrate antigen 19-9 in stage 0, I, and II patients. The combination of all three markers yielded similar sensitivity for patients with disease of stage 0: 57.1%, I: 36.1%, II: 45.2%, and III: 55.4%, whereas the sensitivity reached 85.7% for patients with stage IV disease.
CONCLUSION: VIM methylation of serum DNA may be a useful marker for the early detection of CRC.
Atsushi Shirahata; Kenji Hibi
Related Documents :
24863428 - Activation of lymphocyte autophagy/apoptosis reflects hemodynamic inefficiency and func...
24672658 - Symptom characteristics and psychosomatic profiles in different spectrum of gastroesoph...
23713678 - Cerebral oximetry values in dialyzed surgical patients: a comparison between hemodialys...
23764858 - Effect of training on inspiratory load compensation in weaned and unweaned mechanically...
25224848 - Prospective validation study of transorbital doppler ultrasound imaging for the detecti...
24863428 - Activation of lymphocyte autophagy/apoptosis reflects hemodynamic inefficiency and func...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anticancer research     Volume:  34     ISSN:  1791-7530     ISO Abbreviation:  Anticancer Res.     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-07-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  4121-5     Citation Subset:  IM    
Copyright Information:
Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Search of New Cytotoxic Crude Materials Against Human Oral Squamous Cell Carcinoma Using 1H NMR-base...
Next Document:  Metformin Inhibits Tumor Cell Migration via Down-regulation of MMP9 in Tamoxifen-resistant Breast Ca...